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Objectives: To compare pharmacists‘ and pharmacy technicians‘ perceptions of patients‘ beliefs 
regarding inhaled corticosteroids (ICS) with those of patients and to compare the ICS beliefs of 
pharmacists and technicians with those of patients with asthma. 
Methods: 1269 community pharmacies were approached to fill out an online questionnaire; 1952 
patients were sent a questionnaire by post. Beliefs (i.e. necessity and concerns) regarding ICS 
were measured using (an adapted version of) the Beliefs about Medicines Questionnaire (BMQ-
specific). Pharmacists and technicians were instructed to fill out the BMQ for themselves, and to 
fill it out in the way they thought most of their patients would complete it. 
Results: 136 pharmacists, 90 pharmacy technicians and 161 patients with asthma completed the 
questionnaire. Pharmacists and technicians thought patients had more concerns about ICS than 
patients themselves reported (p<0.0001). They also thought that patients had stronger beliefs in 
their personal need for ICS than patients reported (p<0.01). Pharmacists reported lower levels of 
concerns than patients (p<0.05) and both providers attributed a higher level of necessity to ICS 
than patients did (p<0.0001). 
Conclusion: Pharmacists and technicians overestimate the personal need for treatment as well as 
the concerns patients with asthma have regarding ICS. They also have, to some extent, stronger 
positive beliefs about ICS than patients. If pharmacists and technicians expect that patients share 
their positive views about ICS, they might be less likely to elicit and address patients‘ doubts and 
concerns about ICS, which might be relevant for effective ICS treatment and subsequent patient 
outcomes. 
Keywords 
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Introduction 
Worldwide, an estimated 334 million people are affected by asthma [1]. Patients‘ self-
management skills, such as acquiring knowledge about asthma, self-monitoring of symptoms, 
psychological coping and adhering to medication recommendations, are important in asthma 
treatment [2]. Despite the importance of using inhaled corticosteroids (ICS) regularly and of 
continuously controlling asthma symptoms, about 40% of patients fail to take ICS as prescribed 
by their healthcare provider [3, 4]. This suboptimal adherence is associated with reduced quality 
of life, poor asthma outcomes, morbidity, mortality, and high healthcare use and costs [3, 5-7]. 
Therefore, suboptimal ICS adherence is a significant problem and it is important to find out how 
to improve adherence, which is essential for effective self-management and positive patient 
outcomes. 
Suboptimal adherence is related to beliefs about medicines, and, in particular to how 
patients judge their personal need for treatment (necessity beliefs) compared to their concerns 
about potential negative effects. Addressing these beliefs could therefore contribute to better 
adherence [8-11]. Horne and colleagues distinguish between general and specific medication 
beliefs [12]. General medication beliefs include patients‘ thoughts about the harmfulness of 
medicines, overprescribing by doctors, and benefits of medication in general. Specific 
medication beliefs refer to perceptions of personal need for the treatment (necessity beliefs) and 
concerns regarding medicines for a particular disease. Studies indicate that about 30-43% of 
patients with asthma have concerns about ICS, relating to side effects, fear of long-term adverse 
effects and drug dependency [8, 11]. One study found a smaller number of patients with high 
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concern rates than other studies have reported (23%), but showed that more than one third of the 
patients doubted the necessity of ICS [13]. 
To facilitate informed choice, optimal adherence to appropriately prescribed treatment, 
and self-management, healthcare providers should take patients‘ medication beliefs into account. 
In their interactions with patients, they can accomplish this by being alert, empathic and 
responsive to patients‘ concerns, feelings, and ideas regarding their medication use. Such a 
patient-centered approach, ‗in which the patient‘s point of view is actively sought‘ [14], is 
considered to enhance patient satisfaction, medication adherence, and health outcomes, although 
literature studies yield inconsistent findings [15, 16]. 
The level to which healthcare providers communicate in a patient-centered way and are 
able to achieve concordance — i.e. a shared responsibility by providers and patients in treatment 
and therapeutic decisions, whereby patients‘ beliefs and preferences are taken into account [8, 
17] — might be reflected in an accurate perception of patients‘ medication beliefs. Such 
perceptions are built during providers‘ interactions with patients. In turn, if healthcare providers‘ 
perceptions of patients‘ medication beliefs correspond with patients‘ actual beliefs, this might 
enhance their responsiveness (i.e. being attentive and sensitive) to patients‘ concerns and doubts 
about the need for ICS. No previous research has examined providers‘ perceptions of patients‘ 
beliefs. Therefore, it is interesting to get insight into providers‘ perceptions of patients‘ beliefs 
and to compare these with patients‘ actual beliefs. 
Additionally, healthcare providers‘ own beliefs are likely to influence the degree of 
patient-centered communication and the concordance that can be achieved. If providers and 
patients hold the same medication beliefs, the providers might be expected to be more responsive 
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to their patients‘ doubts and concerns about ICS and elicit them. However, if providers have a 
more positive view of ICS than patients, they might be more inclined to assume that patients 
have similar beliefs, and therefore fail to extensively explore patients‘ thoughts. Few studies 
have examined these issues but there is some evidence that healthcare providers have more 
positive views about medicines in general than patients do [18, 19]. In addition, Rämstrom and 
colleagues showed that pharmacists have more positive medication beliefs than patients do, and 
therefore they emphasized that it is important that pharmacists elicit patients‘ views, experiences 
and concerns; pharmacists must not assume that patients are as positive about medication as they 
are themselves [20]. 
In this study we concentrate on specific medication beliefs, in particular perceptions of the 
necessity of ICS and concerns, as held by patients with asthma, community pharmacists, and 
pharmacy technicians. Regarding adherence to ICS, specific medication beliefs are likely to be 
most salient, in particular perceptions of the necessity of ICS and concerns [10]. We focus on the 
setting of the community pharmacy since patient counseling has become a pivotal task of 
community pharmacists [21]. 
To gain more insight into differences in ICS beliefs between patients with asthma and 
providers, the objectives of this study are: 1) to compare pharmacists‘ and pharmacy technicians‘ 
perceptions of patients‘ ICS beliefs with the ICS beliefs of the patients themselves, and 2) to 
compare the ICS beliefs of patients with asthma with the beliefs of pharmacists and pharmacy 
technicians. Pharmacists‘ and pharmacy technicians‘ beliefs will be examined separately as 
several studies found differences in their communication and beliefs [19, 22, 23]. 
Methods 
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Setting 
This cross-sectional study is part of a larger research project investigating the communication of 
community pharmacists and pharmacy technicians with patients with asthma and/or Chronic 
Obstructive Pulmonary Disease (COPD) about their ICS use. 
Data for this study were obtained in two different ways. Patients‘ data were obtained in 
twelve community pharmacies between September 2011 and February 2012; the methods used 
are described in the ―Patient part‖. Pharmacists‘ and pharmacy technicians‘ data were obtained 
between January 2014 and March 2014; the methods for this are described in the ―Pharmacy 
part‖. 
Ethics 
The research proposal was assessed by the Medical Ethics Committee (METC) of the University 
Medical Center Utrecht (UMCU). The METC concluded that it did not fall within the remit of 
the Law on Medical Scientific Research involving Human Beings. 
Patient part (September 2011 – February 2012) 
Participants 
Eligible patients were 18 years of age or older, had been using ICS for at least one year, and had 
filled two or more ICS prescriptions in the preceding year; the latter criterion was in order to 
include only daily ICS users. Patients who were living in an institution (e.g., a nursing home or 
assisted living facility) were excluded. For the purpose of the present study, data were used only 
of patients who reported having asthma (symptoms) without COPD. 
Procedure 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
on
do
n]
 at
 09
:29
 22
 Ju
ne
 20
16
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 
Patients were recruited in twelve community pharmacies; these pharmacies had participated in a 
previous study in cooperation with the Utrecht Pharmacy Practice Network for Education and 
Research (UPPER) [24]. 1952 eligible patients were sent an information package, consisting of 
an invitation letter, a questionnaire, and an informed consent form, by their pharmacists. To 
participate in the study, patients had to return the completed questionnaire and a signed informed 
consent form. 
Pharmacy part (January 2014 - March 2014) 
Participants 
All 1269 community pharmacists belonging to the UPPER network were eligible to participate; 
no further inclusion or exclusion criteria were applied. Pharmacy technicians were eligible if 
they were experienced in instructing patients in inhaler techniques, as determined by the 
pharmacists. 
Procedure 
To recruit pharmacists, UPPER sent an e-mail to the community pharmacists belonging to the 
UPPER network. The e-mail contained information about the study and a secure web link to an 
online questionnaire. To reach more pharmacists and to recruit pharmacy technicians, 
pharmacists were requested to send this e-mail to other pharmacists and pharmacy technicians at 
their pharmacy. The pharmacists and pharmacy technicians from the twelve pharmacies who had 
already participated in the initial study (n=24) were invited to participate again in this study via 
e-mail, and the secure web link was also sent to them. 
Questionnaires and measures 
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The questionnaire for both patients and pharmacists/pharmacy technicians included questions on 
sociodemographic characteristics. Patients were asked about the indication for ICS prescription 
(asthma (symptoms), COPD, or not known). Data on pharmacists‘ and technicians‘ experience in 
education and counseling patients about ICS was collected as well. 
In addition, the validated Beliefs about Medicines Questionnaire (BMQ-specific) was used to 
measure specific beliefs about ICS. This questionnaire had been developed initially for 
patients.[12] The BMQ-specific contains a ‗necessity‘ scale and a ‗concerns‘ scale. An example 
of a ‗necessity‘ item is: ‗Without these medicines, I would be very ill‘, and of a ‗concerns‘ item: 
‗These medicines disrupt my life‘. Each scale consisted of five items originally, but a sixth item, 
i.e. ‗ICS give me unpleasant side effects‘, can be added to the ‗concerns‘ scale, depending on the 
reliability of the scale. All eleven items were included in this study. 
Patients filled out the original version of the BMQ-specific, whereas pharmacists and 
pharmacy technicians completed two versions of the BMQ-specific. First, the BMQ-specific was 
adapted to assess pharmacists‘ and pharmacy technicians‘ own ICS beliefs; these changes were 
approved by the developer of the BMQ-specific [25]. Items were rephrased so that pharmacists 
and pharmacy technicians could answer them from their own perspective. Examples are: ‗These 
medicines disrupt the life of my patients‘ and ‗Without these medicines, my patients would be 
very ill‘. Second, to assess pharmacists‘ and pharmacy technicians‘ perceptions of patients‘ ICS 
beliefs, they had to complete the original, unadapted, BMQ-specific. This time they had to 
complete it from the perspective of their patients. The instruction was to fill it out in the way 
they thought most of their patients with asthma would complete it. 
D
ow
nl
oa
de
d 
by
 [U
niv
ers
ity
 of
 L
on
do
n]
 at
 09
:29
 22
 Ju
ne
 20
16
 
ACCEPTED MANUSCRIPT 
ACCEPTED MANUSCRIPT 
BMQ items were rated on a 5-point Likert scale ranging from ‗strongly disagree‘ to ‗strongly 
agree‘. The scores were added up for each scale, where higher scores indicate stronger beliefs. 
The ‗necessity‘ scale sum scores were divided by 5, resulting in a scale score ranging from 1 to 5 
(midpoint: 3). The internal consistency of the ‗necessity‘ scales was sufficient to good (range of 
Cronbach‘s α: 0.70-0.84). To reach an acceptable internal consistency for all versions of the 
‗concerns‘ scale, the sum score was calculated on the basis of four items instead of five (or six) 
items (range of Cronbach‘s α: 0.60-0.77). The item ‗I have insufficient knowledge about the 
effects of ICS‘ was excluded. Sum scores of the ‗concerns‘ scale were divided by 4, resulting in 
a scale score ranging from 1 to 5 (midpoint: 3). ‗Necessity‘ and ‗concerns‘ scores below the 
scale midpoint (<3) were considered to be ‗low‘, and scores from midpoint and above (≥3) were 
considered to be ‗high‘. 
Statistical analysis 
Data were analyzed using Stata version 13. Descriptive statistics were used to describe the 
characteristics of the study participants. Two-sample t-tests and a Pearson's chi-squared test were 
performed to compare the characteristics of pharmacists and pharmacy technicians who did not 
fill out the questionnaire entirely (i.e. non-completers) with the characteristics of those who did 
complete it. Data for non-responding patients was not available. Two-sample t-tests were also 
performed to compare the mean values of the patient BMQ scores, with the pharmacists‘ and 
pharmacy technicians‘ BMQ scores. 
Results 
Study sample 
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A total of 429 patients (22.0%) responded, of whom 169 patients reported having asthma 
(symptoms) without COPD. Of these, 161 completed the BMQ-specific sufficiently for 
calculations of scale scores and were therefore included in this study. The mean age was 56.2 
years (SD=16.8), and the majority of the patients were female (67.3%). 
Of the 1269 pharmacies approached, 1257 pharmacists received the invitation (there were 
12 e-mail delivery errors). The link to the questionnaire was opened by 174 pharmacists and 106 
pharmacy technicians, and completed by 136 pharmacists and 90 pharmacy technicians. Non-
completers (n=54) did not differ from completers in age, gender, and own medication beliefs 
(these parts were filled in by all pharmacists and pharmacy technicians who opened the link). Of 
the completers, a small majority of the pharmacists were female (56.6%) whereas almost all 
pharmacy technicians were female (98.9%). The mean age of the pharmacists was 41.5 years 
(SD=11.8), and that of the pharmacy technicians was 41.4 years (SD=11.2). 
In everyday practice, approximately one third of the responding pharmacists and a quarter 
of the responding pharmacy technicians reported that they did not provide counseling sessions 
(i.e. consultations in which patients‘ experiences with medication use is discussed to monitor 
patients‘ health and/or medication use) for ICS at their pharmacy (table 1). 
Beliefs about ICS 
Table 2 shows the percentages of patients, pharmacists and pharmacy technicians who had high 
scores on the ‗necessity‘ and ‗concerns‘ scales. The majority of the patients with asthma (65.2%) 
had high scores on the ‗necessity‘ scale, and about one-third (34.8%) had low ‗necessity‘ scores. 
Most patients (78.9%) had low scores on the ‗concerns‘ scale. Regarding the perceptions of 
patients‘ beliefs, most pharmacists (89.7%) and pharmacy technicians (87.8%) assessed patients 
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as having high ‗necessity‘ scores and around 80% of them believed patients to have concerns. 
The majority of pharmacists (95.6%) and pharmacy technicians (92.2%) had high ICS 
‗necessity‘ scores, and low ‗concern‘ scores themselves (86.8% and 80.0%, respectively). 
Table 3 presents the individual items in the BMQ and the patients‘, pharmacists‘ and 
pharmacy technicians‘ mean scores to illustrate the results. The mean scores of the ‗necessity‘ 
items were high for all groups except the item ‗Without ICS I would be very ill‘, which was 
given a mean score below the scale midpoint by the patients. Regarding the personal beliefs of 
patients, pharmacists and pharmacy technicians, the mean scores of the ‗concerns‘ items were 
low, except for the item ‗ICS give my patients unpleasant side effects‘, which had a high score in 
the pharmacy technicians group. On the other hand, all the mean scores of items about 
pharmacists‘ and pharmacy technicians‘ perceptions of patients‘ beliefs were high, except the 
item ‗ICS disrupt my life‘. 
Differences between patients, pharmacists and pharmacy technicians in assessing necessity 
beliefs 
Two-sample t-tests revealed that patients on the one hand and pharmacists and pharmacy 
technicians on the other hand, differ in the (perceived) degree of necessity of ICS (table 4). 
Patients‘ ‗necessity‘ scores (mean=3.2 ± SD=0.8) were lower on average than pharmacists‘ and 
pharmacy technicians‘ perceptions of patients‘ necessity beliefs (pharmacists: 3.5 ± 0.5, p<0.01; 
pharmacy technicians: 3.6 ± 0.6, p<0.001). In addition, the patients‘ mean ICS necessity score 
was significantly lower than the pharmacists‘ own mean score (3.7 ± 0.5, p<0.0001) and the 
pharmacy technicians‘ own mean score (3.6 ± 0.5, p<0.0001). No significant differences were 
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found between the pharmacists‘ ‗necessity‘ scores and the pharmacy technicians‘ scores, or 
between the two groups‘ perceptions of patients‘ necessity beliefs. 
Differences between patients, pharmacists and pharmacy technicians in assessing concerns 
Pharmacists and pharmacy technicians thought that patients‘ ‗concerns‘ scores were higher than 
the actual patients‘ ‗concerns‘ scores (patients: 2.3 ± 0.8; pharmacists: 3.3 ± 0.5, p<0.0001; 
pharmacy technicians: 3.3 ± 0.6, p<0.0001) (table 5). Patients had a significantly higher mean 
‗concerns‘ score than pharmacists (2.1 ± 0.7, p<0.05), but no difference was found with 
pharmacy technicians‘ own concerns. Pharmacists‘ mean ‗concerns‘ score was significantly 
lower than pharmacy technicians‘ mean ‗concerns‘ score (2.1 ± 0.7 vs. 2.4 ± 0.5, p<0.0001), but 
their perceptions of patients‘ concerns did not differ. 
Discussion 
Our findings show that there are differences in ICS beliefs between patients with asthma, 
community pharmacists and pharmacy technicians, and between patients‘ beliefs and 
pharmacists‘ and pharmacy technicians‘ perception of patients‘ beliefs. Pharmacists and 
pharmacy technicians overestimate the extent to which patients consider ICS to be a necessity, 
but they also overestimate the extent of the concern beliefs. Their perceptions of patients‘ 
concern beliefs are different from their own beliefs. Pharmacists, and to some extent pharmacy 
technicians, hold more positive beliefs about ICS than asthma patients. 
First, pharmacists and pharmacy technicians thought patients would rate their personal 
need for ICS much higher than they actually did. Their overestimation of patients‘ ICS necessity 
beliefs might suggest that pharmacists and pharmacy technicians are not yet paying enough 
attention to patients‘ necessity beliefs. However, it seems important to emphasize the need for 
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ICS in the enhancement of adherence since a positive relationship between necessity beliefs and 
ICS adherence has been found [10, 11, 13]. Our results also show that about one-third of the 
patients doubted the necessity of ICS, so the necessity beliefs of ICS could be strengthened in 
this large group. That patients doubt the necessity of ICS might be due to the perception that ICS 
are not associated with the immediate relief of the symptoms of airways constriction in the same 
way that bronchodilators are [10]. The inflammatory effect of ICS can be seen only in the long 
term, so the effect is not as noticeable as the effect of bronchodilators. Providing more 
information and increasing knowledge about ICS might therefore be of importance.[26] 
In contrast, pharmacist and pharmacy technicians expected that patients would experience 
more concerns about ICS than patients actually did. Although pharmacists themselves are less 
concerned, they imagine that patients can be concerned. It has to be noted that in this study fewer 
patients (21.1%) had concerns than in previous studies, in which more than one third of patients 
with asthma were reported to have concerns [8, 11]. In the light of the results of these earlier 
studies, the perceptions of patients‘ ICS concerns by pharmacists and pharmacy technicians 
might be not as much of an overestimate as is suggested in our study. 
Furthermore, regarding pharmacists‘ and pharmacy technicians‘ own beliefs, we found 
that both categories of provider have higher ICS necessity beliefs than patients do. Pharmacists 
have fewer concerns about ICS than patients. So pharmacists have more positive beliefs about 
ICS than patients do (because pharmacists gave higher scores for the necessity of ICS and lower 
scores for concerns), and pharmacy technicians are more positive in terms of ICS necessity. 
These discrepancies in ICS beliefs between providers and patients could hinder providers in 
achieving patient-centered communication and alignment. If providers have few concerns about 
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potential adverse effects, they might assume that their patients share a similar positive view of 
the treatment and therefore be less inclined to elicit specific concerns (e.g. side effects, long-term 
effects, fear of dependency) that might be of importance to the patient and even act as a barrier to 
adherence and persistence. 
To prevent possible negative influences of discrepancies in communication, more attention 
should be paid to patients‘ beliefs about medication and how these are related to medication 
adherence. George and colleagues have explored the themes that are discussed during contacts 
between patients with asthma and their primary care provider. They found that providers initiate 
a talk about modifiable ICS beliefs only when they have prior knowledge of patients‘ negative 
ICS beliefs [27]. Also, healthcare providers‘ medication beliefs and their perceptions of patients‘ 
beliefs should be taken into account. Being aware of providers‘ own thoughts, possible 
discrepancies, and (unconscious) processes in behavior and communication could make 
communication more patient-centered. Besides, just communicating in a more patient-centered 
way could change providers‘ perceptions of patients‘ beliefs. Using more patient-centered 
communication enables the healthcare provider to learn about patients‘ thoughts and concerns 
and could change their incongruent perceptions. The results might indicate that pharmacists and 
pharmacy technicians need to improve their affective and responsive communication skills (e.g. 
through training and educational courses) to become more patient-centered and to explore and 
elicit the actual beliefs of patients more thoroughly. 
Findings from this study indicate that pharmacists and pharmacy technicians differ in their 
concerns about ICS. Pharmacy technicians are somewhat more concerned than pharmacists, but 
they have a similar assessment of the necessity of ICS. The result is in line with a previous study 
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that showed that pharmacy technicians held slightly more negative general beliefs about 
medication than pharmacists; to some extent, pharmacy technicians thought medicines to be 
more harmful, whereas pharmacists believed medicines to be slightly more beneficial [19]. 
Pharmacy technicians and patients do not differ in their own degree of ICS concerns. A possible 
explanation for this similarity is that technicians have more frequently contact with patients than 
pharmacists [28], which might influence the pharmacy technicians‘ beliefs. 
We showed that pharmacists‘ and pharmacy technicians‘ perceptions of patients‘ beliefs 
and their own beliefs differ from those of patients with asthma, which might have clinical 
implications. More research is needed to study whether this incongruence affects patient-
provider communication, ICS adherence and consequently self-management and patient 
outcomes, such as quality of life and asthma control. 
We suggest that it is important to make pharmacists and pharmacy technicians aware of 
the fact that patients‘ beliefs in the necessity of ICS are not as strong as they expect. A topic for 
future research is the question of whether making providers aware of their patients‘ perceptions 
is sufficient for them to act in a more patient-centered way or whether their own ICS beliefs are 
more dominant in influencing their communicative behavior. The relationship between the 
agreement between providers‘ beliefs and patients‘ beliefs on the one hand and achieving 
concordance on the other is also a new subject to investigate. 
Limitations 
To our knowledge, this is the first study comparing patients‘ ICS beliefs with the beliefs of 
pharmacists and pharmacy technicians. In addition, no previous research also took healthcare 
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providers‘ perceptions of patients‘ beliefs into account, which is a valuable addition to the 
research on provider-related characteristics and communication. 
However, there are some limitations. We were not able to make pairwise comparisons 
between pharmacies and their own patients and therefore we could not investigate the actual 
discrepancies between patients‘ beliefs and their providers‘ beliefs and perceptions. Instead, the 
measured providers‘ perceptions about patients‘ beliefs are, in a way, ‗generalizations‘. A more 
robust methodology for this type of study would be a one-to-one comparison where the patient 
fills out the BMQ and the pharmacists or technician fills out the BMQ for that specific patient. 
Furthermore, the BMQ was originally developed to measure patients’ medication beliefs. 
In our study, we also used the BMQ to assess the ICS beliefs of pharmacists and technicians and 
their perceptions of patients‘ ICS beliefs. As reported in this paper, the internal consistency of 
the different ‗concerns‘ scales was not high, and therefore not all the original items have been 
included in this scale. Because the BMQ was not developed and validated for use in this way, the 
outcomes should be interpreted carefully. In future research, the development and validation of 
comparable tools is of importance in order to measure healthcare providers‘ beliefs and their 
perceptions of patients‘ beliefs in a sound way. 
Another limitation is that the selection of our sample of patients with asthma (symptoms) 
was based on self-report. Such self-reported diagnostics are not entirely reliable because of their 
subjectivity, and this might have consequences for the representativeness of our sample and the 
implications that follow from our results. It is possible that we have included patients with 
Chronic Obstructive Pulmonary Disease (COPD). Because of the differences in the nature and 
implications of these diseases, patients with COPD might have different experiences with and 
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beliefs about ICS than patients with asthma. However, suboptimal ICS adherence is a problem in 
patients with COPD as well [29, 30]. Also, it has been found that beliefs (e.g. concerns about 
medication) are related to suboptimal medication adherence in patients with COPD [31, 32]. 
Therefore, the two different patient groups are not likely to differ greatly in their ICS beliefs. 
Also, selection bias could have occurred, which can limit the generalizability of our 
results. Participating pharmacists, pharmacy technicians and patients could have different 
characteristics to non-participants because they could be more engaged in this topic of research, 
and therefore could have non-representative beliefs about asthma and ICS. The occurrence of 
selection bias could be an explanation for different findings compared to other studies regarding 
the level of patients‘ concerns. In addition, the average age of the patients in our study sample 
was 56.2 years, which is higher than the average age of the general population of patients with 
asthma in the Netherlands and therefore limits the representativeness of our sample [33]. 
Finally, the data were obtained in two different periods, in 2011-2012 and in the 
beginning of 2014. This difference might have influenced our outcomes, as significant 
information on ICS might have been published between these two periods, making the two 
periods less comparable. However, there were no new developments regarding ICS between the 
two measurements. 
Conclusion 
Pharmacists and technicians seem to judge patients to have stronger necessity beliefs than is 
actually the case. When pharmacists and technicians were asked to report the views of a ‗typical 
patient‘, they reported patients as being more convinced of their need for daily ICS than reflected 
in the mean ratings for ICS necessity beliefs reported by patients. Pharmacists and pharmacy 
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technicians generally hold more positive beliefs about ICS than patients with asthma. If 
pharmacists and technicians assume that patients share their positive views about ICS, this might 
mean that they will be less likely to elicit patients‘ ICS doubts and concerns and therefore will be 
less likely to address the beliefs that act as barriers to adherence and persistence to essential 
medication for asthma. 
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Table 1. Patient, pharmacist and pharmacy technician characteristics and attitudes 
a
2 missing values 
b
4 missing values 
Patient characteristics n=161 
Female
a 107(67.3%) 
Age in years
a  
Mean (SD)  56.2(16.8) 
(range) (20-87) 
Age group, years
a  
18-44 42(26.1%) 
45-64 64(39.8%) 
65 or over 53(32.9%) 
Educational level
a  
Low 25(15.5%) 
Intermediate 58(36.0%) 
High 76(47.2%) 
Ethnicity
b  
Dutch 124(77.0%) 
Western background 21(13.0%) 
Non-Western background 12(7.5%) 
Pharmacist and pharmacy technician 
characteristics 
Pharmacists n=136 Pharmacy technicians 
n=90 
Female  77(56.6%) 89(98.9%) 
Age in years   
Mean (SD) 41.5(11.8) 41.4(11.2) 
(range) (25-76) (20-63) 
Experience with dispensing of first and 
second ICS prescriptions (DP) and 
counseling sessions (CS) with patients 
about ICS  
DP CS DP CS 
No 0 31(22.8%) 0 24(26.7%) 
Yes, usually at the counter 40(29.4%) 59(43.4%) 12(13.3%) 41(45.6%) 
Yes, usually in private room 96(70.6%) 46(33.8%) 78(86.7%) 25(27.8%) 
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Table 2. Percentages of patients, pharmacists and pharmacy technicians giving a high score on 
the ‗necessity‘ and ‗concerns‘ scales. 
 Patients Pharmacists: 
perceptions 
of patients’ 
beliefs 
Pharmacists Pharmacy 
technicians: 
perceptions of 
patients’ 
beliefs 
Pharmacy 
technicians 
High score 
on 
‘necessity’ 
scale 
65.2% 89.7% 95.6% 87.8% 92.2% 
High score 
on 
‘concerns’ 
scale 
21.1% 78.7% 13.2% 84.4% 20.0% 
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Table 3. Mean scores for all original and adapted items of the BMQ-Specific 
 Patients
1 
Pharmacists: 
perceptions of 
patients‘ beliefs1 
Pharmacists
2 
Pharmacy 
technicians: 
perceptions of 
patients‘ beliefs1  
Pharmacy 
technicians
2 
 M(SD) M(SD) M(SD) M(SD) M(SD) 
Necessity items      
1
My health, at 
present, depends on 
ICS 
2My patients‘ health, 
at present, depends 
on ICS 
3.2(1.1) 3.5(0.8) 3.6(0.8) 3.6(0.9) 3.4(0.8) 
1
My life would be 
impossible without 
ICS 
2My patients‘ life 
would be impossible 
without ICS
 
3.3(1.0) 3.5(0.8) 3.9(0.7) 3.7(0.7) 3.7(0.7) 
1
Without ICS I 
would be very ill 
2
Without ICS my 
patients would be 
very ill 
2.8(1.2) 3.4(0.8) 3.5(0.8) 3.6(0.8) 3.5(0.8) 
1
My health in the 
future will depend on 
ICS 
2
The future health of 
my patients will 
depend on ICS
 
3.3(0.9) 3.4(0.7) 3.7(0.7) 3.4(0.8) 3.5(0.7) 
1
ICS protect me from 
becoming worse 
2
These medicines 
protect my patients 
from becoming 
worse
 
3.5(0.9) 3.7(0.6) 4.1(0.6) 3.7(0.6) 4.0(0.5) 
Concern items      
1
Having to take ICS 
worries me 
2
It worries me that 
my patients have to 
take ICS 
2.2(1.0) 3.6(0.8) 2.0(0.8) 3.5(0.8) 2.3(0.7) 
1&2
I sometimes 
worry about long-
term effects of ICS 
2.9(1.3) 3.8(0.7) 2.4(0.9) 3.7(0.8) 2.9(0.8) 
1&2
I have insufficient 2.5(1.1)
a
 3.2(0.9) 2.2(1.2) 3.1(0.9) 2.6(1.2) 
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knowledge about the 
effects of ICS
* 
1
ICS disrupt my life 
2
ICS disrupt the life 
of my patients 
1.6(0.8) 2.5(0.7) 1.9(0.8) 2.7(0.9) 2.2(0.6) 
1
I sometimes worry 
about becoming too 
dependent on ICS 
2
I sometimes worry 
that my patients are 
becoming too 
dependent on ICS 
2.3(1.1) 3.2(0.8) 2.1(1.0) 3.5(0.9) 2.4(0.7) 
1
ICS give me 
unpleasant side 
effects
*
 
2
ICS give my 
patients unpleasant 
side effects
* 
2.3(1.1)
b
 3.4(0.7) 2.8(0.9) 3.4(0.7) 3.1(0.8) 
BMQ-Specific, 
©
Professor Robert Horne, University of Brighton 
Mean BMQ-scores range between 1-5. Higher scores refer to stronger beliefs. 
a
2 missing values 
b
1 missing value 
1
Original BMQ-item, and which group answered it 
2
Adapted BMQ-item, and which group answered it 
*
Not included for calculation of sum score of ‗concerns‘ scale 
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Table 4. Results of two-sample t-tests of differences in the ICS necessity beliefs of patients with asthma, 
pharmacists and pharmacy technicians, and of pharmacists‘ and pharmacy technicians‘ perceptions of 
patients‘ necessity beliefs. 
  
 M(SD) Pharmacists: 
perceptions of 
patients’ 
necessity beliefs 
Pharmacists  Pharmacy 
technicians: 
perceptions of 
patients’ 
necessity beliefs 
Pharmacy 
technicians  
3.5(0.5) 3.7(0.5) 3.6(0.6) 3.6(0.5) 
Patients 3.2(0.8) p<0.01 p<0.0001 p<0.001 p<0.0001 
Pharmacists: 
perception of 
patients’ 
necessity beliefs 
3.5(0.5) - - ns - 
Pharmacists  3.7(0.5) - - - ns 
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Table 5. Results of two-sample t-tests of differences in the ICS concerns of patients with asthma, 
pharmacists, and pharmacy technicians, and of pharmacists‘ and pharmacy technicians‘ 
perceptions of patients‘ concerns. 
 
 M(SD) Pharmacists: 
perceptions of 
patients’ 
concerns 
Pharmacists Pharmacy 
technicians: 
perceptions of 
patients’ 
concerns 
Pharmacy 
technicians 
3.3(0.5) 2.1(0.7) 3.3(0.6) 2.4(0.5) 
Patients 2.3(0.8) p<0.0001 p<0.05 p<0.0001 ns 
Pharmacists: 
perceptions of 
patients’ 
concerns 
3.3(0.5) - - ns - 
Pharmacists  2.1(0.7) - - - p<0.0001 
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